Matthew Ronsheim

Matthew Ronsheim

Chief Operating Officer at XENON PHARMACEUTICALS INC.
54 year
Health Technology
Consumer Services
Commercial Services

Profile

Matthew D.
Ronsheim
is Chief Operating Officer at Xenon Pharmaceuticals, Inc. since 2024.
Formerly, Dr. Ronsheim was Executive Director & Head-Chemistry Manufacturing at Enanta Pharmaceuticals, Inc. from 2016 to 2019 and Chief Pharmaceutical Sciences Officer at Entasis Therapeutics Holdings, Inc. Education includes undergraduate studies at Southern Connecticut State University and a doctorate from the University of New Hampshire.

Matthew Ronsheim active positions

CompaniesPositionStart
XENON PHARMACEUTICALS INC. Chief Operating Officer 12/08/2024

Former positions of Matthew Ronsheim

CompaniesPositionEnd
ENANTA PHARMACEUTICALS, INC. Director/Board Member 01/08/2019
ENTASIS THERAPEUTICS HOLDINGS INC. Corporate Officer/Principal -
See the detail of Matthew Ronsheim's experience

Training of Matthew Ronsheim

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

9

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Health Technology

Consumer Services

Consumer Services

Health Technology

Commercial Services

  1. Stock Market
  2. Insiders
  3. Matthew Ronsheim
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!